IDO1 regulation of SR-BI and cholesterol homeostasis in macrophages

IDO1 对巨噬细胞中 SR-BI 和胆固醇稳态的调节

基本信息

  • 批准号:
    10731003
  • 负责人:
  • 金额:
    $ 45.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Inflammation is a fundamental biological process that plays key roles in immune response. However, uncontrolled, and chronic inflammation are the root causes of many human diseases including metabolic disorders, obesity, insulin resistance, diabetes, hypertension, and atherosclerosis. Macrophage activation plays a central role in inflammation, regulates the host defense during pathogenic infection, and maintain tissue homeostasis. Recent studies indicate that macrophage functions are influenced by lipid metabolism.10-15 The imbalance in lipid uptake, metabolism, and removal in macrophages cause tissue trans-differentiation contributing to hyperlipidemia and metabolic syndrome. For example, macrophages and derived foams cells are the hallmarks of atherosclerosis. The signaling mechanism associated with lipid homeostasis and metabolism in macrophages is complex and poorly understood. The primary goal of this proposal is to investigate the cholesterol homeostasis mechanism in macrophages under inflammation. In particular, HDLR-SR-BI (SR-BI), a receptor for the cholesterol-rich HDL, facilitates the selective delivery of HDL-cholesteryl ester to the liver. It promotes atheroprotection via HDL metabolism. SR-BI is also expressed in in macrophages and regulates lipid homeostasis. In a preliminary study, we observed that the SR-BI expression is downregulated in macrophages upon LPS stimulation, and this is potentially regulated viaIndoleamine-2,3-dioxygenase 1 (IDO1). We found that IDO1 and its down-stream catabolite, kynurenine (KYN), are also elevated in LPS-stimulated macrophages and inhibition of IDO1 reversed the LPS-induced downregulation of SR-BI, suggesting potential role of IDO1 in SR- BI expression and cholesterol homeostasis, in macrophages. Notably, KYN is a ligand for aryl hydrocarbon receptor (AhR) which regulates genotoxic stress and inflammatory response. Here, we propose biochemical and cell-based experiments to investigate the roles of IDO1 and KYN-AhR signaling in SR-BI expression and cholesterol homeostasis, in macrophages (aim 1). In the aim 2, we propose to investigate the roles of IDO1 in hepatic inflammation, Kupffer cells (resident macrophage in liver) activation, SR-BI expression, and cholesterol homeostasis in vivo using ovariectomized (OVX) rat as animal model. Overall, our studies will lead to the discovery of novel signaling pathways associated with SR-BI expression and cholesterol homeostasis in macrophages under inflammation. In addition to addressing an important scientific problem, this proposal will also serve to enrich student (especially undergraduates) research experiences at UTA, a minority-serving institution. 1
炎症是一种基本的生物学过程,在免疫反应中起着关键作用。然而,在这方面, 不受控制的慢性炎症是许多人类疾病(包括代谢性疾病)的根本原因 疾病、肥胖症、胰岛素抵抗、糖尿病、高血压和动脉粥样硬化。巨噬细胞活化作用 在炎症中起核心作用,在病原感染期间调节宿主防御,并维持组织 体内平衡最近的研究表明,巨噬细胞的功能受到脂质代谢的影响。 巨噬细胞中脂质摄取、代谢和清除不平衡导致组织转分化 导致高脂血症和代谢综合征。例如,巨噬细胞和衍生的泡沫细胞是 动脉粥样硬化的特征与脂质稳态和代谢相关的信号机制 巨噬细胞是复杂的和知之甚少。本提案的主要目标是调查 炎症状态下巨噬细胞胆固醇稳态机制的研究特别是HDLR-SR-BI(SR-BI), 作为富含胆固醇的HDL的受体,其促进HDL-胆固醇酯向肝脏的选择性递送。它 通过HDL代谢促进动脉粥样硬化保护。SR-BI也在巨噬细胞中表达,并调节脂质 体内平衡在初步研究中,我们观察到SR-BI在巨噬细胞中表达下调, 在LPS刺激下,这可能通过吲哚胺-2,3-双加氧酶1(IDO 1)调节。我们发现 IDO 1及其下游分解代谢物犬尿氨酸(KYN)在LPS刺激的巨噬细胞中也升高, IDO 1的抑制逆转了LPS诱导的SR-BI下调,表明IDO 1在SR-1中的潜在作用。 巨噬细胞中的BI表达和胆固醇稳态。值得注意的是,KYN是芳基烃的配体, 受体(AhR),调节遗传毒性应激和炎症反应。在这里,我们提出了生物化学和 基于细胞的实验,以研究IDO 1和KYN-AhR信号传导在SR-BI表达中的作用, 胆固醇稳态,在巨噬细胞(目的1)。在目的2中,我们建议研究IDO 1在以下方面的作用: 肝脏炎症、枯否细胞(肝脏中的常驻巨噬细胞)活化、SR-BI表达和胆固醇 使用卵巢切除(OVX)大鼠作为动物模型的体内稳态。总的来说,我们的研究将导致 发现与SR-BI表达和胆固醇稳态相关的新信号通路, 炎症下的巨噬细胞除了解决一个重要的科学问题外,这项提案还将 也有助于丰富学生(特别是本科生)在UTA的研究经验,少数民族服务 机构。 1

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Subhrangsu S Mandal其他文献

Subhrangsu S Mandal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Subhrangsu S Mandal', 18)}}的其他基金

Roles of MLL histone methyalses in estrogen mediated regulation of HDLR-SRB1
MLL 组蛋白甲基化在雌激素介导的 HDLR-SRB1 调节中的作用
  • 批准号:
    7882188
  • 财政年份:
    2010
  • 资助金额:
    $ 45.75万
  • 项目类别:
Endocrine Disruptors: Assessment of endocrine disruption activity, mechanism and
内分泌干​​扰物:评估内分泌干扰活性、机制和
  • 批准号:
    7940433
  • 财政年份:
    2010
  • 资助金额:
    $ 45.75万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 45.75万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 45.75万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 45.75万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 45.75万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 45.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 45.75万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 45.75万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 45.75万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 45.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 45.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了